Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry
Europace · 2023
DOI: 10.1093/europace/euae021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, 2023. Verfasst von Giulio Francesco Romiti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverp…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Disease, Chronic Obstructive, Stroke. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.
Themen: COPD
Abstract (Originalsprache)
Aims
Chronic obstructive pulmonary disease (COPD) may influence management and prognosis of atrial fibrillation (AF), but this relationship has been scarcely explored in contemporary global cohorts. We aimed to investigate the association between AF and COPD, in relation to treatment patterns and major outcomes. Methods and results From the prospective, global GLORIA-AF registry, we analysed factors associated with COPD diagnosis, as well as treatment patterns and risk of major outcomes in relation to COPD. The primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACEs). A total of 36 263 patients (mean age 70.1 ± 10.5 years, 45.2% females) were included; 2,261 (6.2%) had COPD. The prevalence of COPD was lower in Asia and higher in North America. Age, female sex, smoking, body mass index, and cardiovascular comorbidities were associated with the presence of COPD. Chronic obstructive pulmonary disease was associated with higher use of oral anticoagulant (OAC) [adjusted odds ratio (aOR) and 95% confidence interval (CI): 1.29 (1.13–1.47)] and higher OAC discontinuation [adjusted hazard ratio (aHR) and 95% CI: 1.12 (1.01–1.25)]. Chronic obstructive pulmonary disease was associated with less use of beta-blocker [aOR (95% CI): 0.79 (0.72–0.87)], amiodarone and propafenone, and higher use of digoxin and verapamil/diltiazem. Patients with COPD had a higher hazard of primary composite outcome [aHR (95% CI): 1.78 (1.58–2.00)]; no interaction was observed regarding beta-blocker use. Chronic obstructive pulmonary disease was also associated with all-cause death [aHR (95% CI): 2.01 (1.77–2.28)], MACEs [aHR (95% CI): 1.41 (1.18–1.68)], and major bleeding [aHR (95% CI): 1.48 (1.16–1.88)].
Conclusion
In AF patients, COPD was associated with differences in OAC treatment and use of other drugs; Patients with AF and COPD had worse outcomes, including higher mortality, MACE, and major bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
- Department of Translational and Precision Medicine, Sapienza - University of Rome, Rome, Italy.
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
- Service de Cardiologie, Centre Hospitalier Régional Universitaire et Faculté de Médecine de Tours, Tours, France.
- Department of General Surgery and Surgical Specialties 'Paride Stefanini', Sapienza - University of Rome, Rome, Italy.
- Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, USA.
ORCID-Profile: Giulio Francesco Romiti, Bernadette Corica, Davide Antonio Mei, Frederick Frost, Arnaud Bisson, Giuseppe Boriani, Tommaso Bucci, Brian Olshansky, Tze-Fan Chao, Menno V Huisman, Marco Proietti, Gregory Y H Lip
Förderung
- Boehringer Ingelheim
Zitieren
APA
Romiti, G. F., Corica, B., Mei, D. A., Frost, F., Bisson, A., Boriani, G., Bucci, T., Olshansky, B., Chao, T. F., Huisman, M. V., Proietti, M., & Lip, G. Y. H. (2023). Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry. Europace. https://doi.org/10.1093/europace/euae021
Vancouver
Romiti GF, Corica B, Mei DA, Frost F, Bisson A, Boriani G, et al. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry. Europace. 2023. doi:10.1093/europace/euae021
BibTeX
@article{Romiti2023,
author = {Romiti, Giulio Francesco and Corica, Bernadette and Mei, Davide Antonio and Frost, Frederick and Bisson, Arnaud and Boriani, Giuseppe and Bucci, Tommaso and Olshansky, Brian and Chao, Tze-Fan and Huisman, Menno V and Proietti, Marco and Lip, Gregory Y H},
title = {Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euae021}
}
EUVIMED